Effectively manage elevated lipid levels with our range of high-quality statins and targeted therapies, critically designed to mitigate the risk of cardiovascular disease.
Cholesterol is a waxy substance that travels in the bloodstream and is essential for building cell membranes and certain hormones. When the body produces too much, or when dietary intake is high, the level of cholesterol in the blood can rise above the normal range. Elevated cholesterol is often referred to as high-cholesterol or hypercholesterolaemia and is a recognised risk factor for heart disease and stroke.
People who monitor their blood-lipid profile may look for ways to keep cholesterol within the target range recommended by health authorities in Hong Kong. Managing cholesterol usually involves lifestyle adjustments together with medications that help the body lower the amount of low-density lipoprotein (LDL) cholesterol and, in some cases, raise high-density lipoprotein (HDL) cholesterol.
A range of medicines is available for this purpose. Medications such as Atorvastatin Calcium, Rosuvastatin and Simvastatin belong to the most widely used group, while other agents target cholesterol absorption or the removal of bile acids.
These treatments are typically taken on a regular basis, forming part of a long-term plan to support heart health and reduce the likelihood of cardiovascular events.
Typical signs that prompt blood-test screening include fatigue, occasional chest discomfort, or a family history of heart disease, although high cholesterol itself often shows no obvious symptoms. Persistent elevation can lead to plaque buildup in arteries, which may eventually affect daily activities such as walking, climbing stairs or performing moderate exercise.
Each category targets a specific aspect of cardiovascular health, and clinicians may combine them when a comprehensive risk-reduction strategy is required.
Statins - inhibit an enzyme involved in cholesterol production, leading to lower LDL levels.
Cholesterol absorption inhibitor - blocks the intestinal uptake of dietary cholesterol.
Fibrate - primarily reduces triglycerides but also modestly improves LDL and raises HDL.
Bile-acid sequestrant - binds bile acids in the gut, prompting the liver to use more cholesterol to make new bile acids.
ATP-citrate lyase inhibitor - interferes with an early step of cholesterol synthesis, offering an alternative for patients who need a non-statin option.
These classes differ in how they act on the body’s lipid pathways, and each offers a distinct option within the broader cholesterol-management portfolio.
Cholesterol management follows a straightforward principle: reduce the amount of LDL that circulates in the blood while maintaining or modestly increasing HDL. The most common therapeutic approach begins with a statin, because this class has the strongest evidence for lowering cardiovascular risk. If a statin alone does not achieve the desired lipid level, clinicians may add a second-line agent such as ezetimibe or a bile-acid sequestrant.
For most people, cholesterol-lowering therapy is a chronic, daily routine rather than a short-term course. The aim is to keep lipid numbers stable over many years, supporting long-term heart health. Short-term use may occur after a specific cardiac event, when the priority is to bring the lipid profile quickly into a safer range.
These scenarios illustrate the typical contexts in which cholesterol-lowering medicines are considered.
LDL (Low-density lipoprotein): The form of cholesterol that transports fat from the liver to the arteries and is often labelled “bad” cholesterol.
HDL (High-density lipoprotein): The “good” cholesterol that carries excess cholesterol back to the liver for disposal.
Statin: A medication class that reduces cholesterol synthesis in the liver, leading to lower LDL levels.
Bile-acid sequestrant: A drug that binds bile acids in the intestine, prompting the liver to use more cholesterol to produce new bile.
Lipid panel: A blood test that measures total cholesterol, LDL, HDL and triglycerides.
Cholesterol is a fatty substance needed for cell structure and hormone production. When its level in the blood is high, especially LDL, it can contribute to plaque buildup in arteries, increasing the risk of heart disease and stroke.
They fall into several groups, including statins, cholesterol absorption inhibitors, fibrates, bile-acid sequestrants and ATP-citrate lyase inhibitors. Each class works on a different step of the body’s lipid pathway.
Typically after a blood test shows LDL levels above the target set by local health guidelines, or when other risk factors such as a family history of heart disease are present.
In Hong Kong, over-the-counter products may contain nutrients like plant sterols, but they are not classified as cholesterol-lowering medicines and are used mainly as a dietary supplement.
Most are available as oral tablets or capsules. Some bile-acid sequestrants are supplied as powders that can be mixed with water.
Statins primarily lower LDL cholesterol, while fibrates mainly reduce triglycerides and can modestly raise HDL.
Yes. A balanced diet low in saturated fats, regular physical activity and maintaining a healthy weight are all important factors that support lower cholesterol numbers.
Combination therapy is sometimes employed when a single medicine does not achieve the target lipid level. The choice of agents depends on the individual’s overall health profile.
It is the specific LDL concentration that health authorities recommend for a given risk category, such as low, moderate or high cardiovascular risk.
A frequent misunderstanding is that these medicines work instantly; in reality, they gradually adjust lipid levels over weeks to months.
